Article
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.
The EMBO journal - 1 Apr 1993
Barettino D, Bugge T H, Bartunek P, Vivanco Ruiz M D, Sonntag-Buck V, Beug H, Zenke M, Stunnenberg H G
Abstract excerpt
V-erbA is thought to be an antagonist of thyroid hormone receptor (T3R) function. Here we show that unliganded T3R, but not v-erbA, suppresses retinoic acid (RA)-dependent induction of the RAR-beta 2 promoter by competing for the common dimerization partner, the retinoid X receptor (RXR). Firstly, T3R suppression can be alleviated by co-transfection of RXR. Secondly, T3R, but not v-erbA, competes with RAR for RXR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
